top of page
Search
  • Writer's pictureJean-Manuel Toussaint
    • Jul 16, 2020
    • 1 min read

France : Drug Eluting Stents (DES) market

Updated: Jul 17, 2020

DES market revenues have been flatenning over the past 3 years. In 2019, DES national tariffs (LPPR) decreased of -17.1% (€760 to €630) even though it doesn't reflect real-life tariffs, especially in public hospitals where prices are much lower. Consequently we observe a drop of -3.4% in total revenues (2018 vs 2019 : €201M.).

To get the full report, please contact-us : inquiries@ihmt-medicaldevice.com

Evolution of the Drug Eluting Stents (DES) market revenue over the past 9 years (2011-2019) with a split public and private hospitals
France : Drug Eluting Stents Market per Hospital (€, 2011-2019)

#DES #Coronary #Stent #Angioplasty #Heart #Interventional #Cardiology #Infarction #Hospital #France #Market #Revenue #LPPR

#Coronaire #Angioplastie #Coeur #Infarctus #Hôpital #Hôpitaux #Marché #Revenu

#Cardiologie #interventionnelle

#Abbott #BostonScientific #Medtronic #Biotronik #BBraun #Cordis #CardinalHealth #Hexacath #Terumo #Alvimedica #Stentys #MicroPort #Biosensor #Translumina #Balt

104 views0 comments
bottom of page